E2F1 Expression is Related with the Poor Survival of Lymph Node-positive Breast Cancer Patients Treated with Fluorouracil, Doxorubicin and Cyclophosphamide

The expressions of E2F1 and retinoblastoma protein (pRB) were analyzed in 165 lymph node-positive breast cancers. All patients underwent adjuvant chemotherapy with fluorouracil, doxorubicin and cyclophosphamide (FAC). E2F1 was expressed in 43.6% and pRB was expressed in 46.1%. E2F1 expression was significantly increased in pRB-expressing tumors and was associated with an S-phase fraction. By univariate survival analyses, E2F1 expression and ER were identified as significant prognostic factors for disease recurrence and patient survival. E2F1 was the only significant prognostic factor of patient outcome after FAC chemotherapy by multivariate analysis.

[1]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[2]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[3]  W. Kaelin,et al.  Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. S. Lee,et al.  Clinical implication of altered expression of Mad1 protein in human breast carcinoma , 2000, Cancer.

[5]  J. Nevins,et al.  Toward an understanding of the functional complexity of the E2F and retinoblastoma families. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[6]  C. Sherr.  G1 phase progression: Cycling on cue , 1994, Cell.

[7]  N. Dyson,et al.  pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. , 1997, Genes & development.

[8]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[9]  K. Naka,et al.  Expression of the E2F family in human gastrointestinal carcinomas , 1999, International journal of cancer.

[10]  M. Macleod,et al.  Regulation of BRCA1 Expression by the Rb-E2F Pathway* , 2000, The Journal of Biological Chemistry.

[11]  M. Bisogna,et al.  Expression of E2F-1 and E2F-4 is reduced in primary and metastatic breast carcinomas* , 2001, Breast Cancer Research and Treatment.

[12]  B. Gallie,et al.  The retinoblastoma protein and the cell cycle. , 1992, Seminars in cancer biology.

[13]  T. Jacks,et al.  Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice , 1998, Nature Genetics.

[14]  M. Greenberg,et al.  E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation , 1996, Cell.

[15]  C. Conti,et al.  Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development , 1998, Oncogene.

[16]  T. Jacks,et al.  Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1 , 1996, Cell.

[17]  J. Bartek,et al.  Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression , 1996, Molecular and cellular biology.

[18]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[19]  C. Cordon-Cardo,et al.  Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. , 1999, Journal of the National Cancer Institute.

[20]  A. Levine,et al.  p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Dyson.  The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[22]  P. Jansen-Dürr,et al.  E2F target genes and cell‐cycle checkpoint control , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[23]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[24]  I. Schieren,et al.  Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  H. Irving.  Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis , 2000 .